1290 Broadway, Suite 1000,
Denver , CO, 80203
Denver , CO, 80203
Summary
The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in small-and mid-size companies in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
The fund employs a passive management or indexing approac More
Webiste
Directors
Feb 13, 2024- Rick A. Pederson
- Edmund J. Burke
- Jeremy W. Deems
- Mary K. Anstine
Chief Compliance Officer
- Matthew Sutula
Price
- $ 24.04 ( -4.91 )
-
Apr 10, 2025Last Close
- Net Assets
-
$119M
Apr 26, 2024
- 52-Week High/Low
- $42.4 - $23.6
- Expense Ratio
- -
Performance
YTD
0%
3 Year
-31.24%
5 Year
-30.04%
Best
67.79%
2009
Worst
-57.58%
2008
Company Name |
Holding |
| Krystal Biotech Inc | 3.82 % |
| Alkermes Plc | 3.3 % |
| Immunovant Inc | 3.1 % |
| Avidity Biosciences Inc | 2.89 % |
| Crinetics Pharmaceuticals Inc | 2.87 % |
| Arcellx Inc | 2.52 % |
| Corcept Therapeutics Inc | 2.52 % |
| Denali Therapeutics Inc | 2.39 % |
| Amicus Therapeutics Inc | 2.36 % |
| Merus Nv | 2.32 % |
| More | 2.32 % |
Documents
NAV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SBIO | 0% | 2.2% | 8.4% | -28.1% | -17.6% | 21.4% | 50% | -11.8% | 45.7% | -27.8% | |
| S&P 500 | 1.6% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| q1 | 0% | 8.5% | -10.5% | -20.4% | -1.9% | -24.9% | 28.6% | 4.4% | 12.4% | -31% | ||||
| q2 | 0% | -5.5% | 16.1% | -17.7% | -2.7% | 32% | 0.6% | 13.2% | 8.2% | 3.3% | ||||
| q3 | 0% | 0% | -13.7% | 8.8% | -7% | -1.7% | -14% | 4.9% | 11.9% | 15.3% | ||||
| q4 | 0% | 0% | 25.8% | 0.8% | -7.2% | 24.6% | 33.7% | -24.7% | 5.6% | -12.2% |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 2024 | 0.8% | 11.6% | -3.5% | -8.3% | 2.7% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |